|
Robert 'Bob' Pearson has more than 20 years of management and product experience in the pharmaceutical industry. Mr. Pearson?s past experience includes senior management positions in multi-billion dollar pharmaceutical organizations both domestically and internationally. Prior to joining Dell he worked in Basel Switzerland for Novartis Pharmaceuticals (NYSE:NVS) as head of Global Corporate Communications and as head of Global Pharma Communications where he served on the Pharma Executive Committee. Before his tenure at Novartis Mr. Pearson was president of The Americas for GCI and was responsible for creating and building that firm?s global healthcare practice. He was previously vice president of Global Public Affairs & Media Relations at Rhone-Poulenc Rorer (now Sanofi Aventis) and worked at CIBA-GEIGY (now Novartis) in both communications and field sales. Mr. Pearson has been part of pharmaceutical product launch teams in all regions of the world and has experience with treatments supportive care and cancer patient advocacy. Mr. Pearson graduated from the University of North Carolina at Greensboro with a degree in communications and completed his MBA at Fairleigh Dickinson University. He has served on the boards of Cancer Care and The Huntington's Disease Society of America and currently serves on the boards of The Dell Foundation The Association for Multiple Impaired and Blind and as vice-chair of The Emerging Technology Committee for the State of Texas. | 